20 Stocks Moving In Monday's Pre-Market Session

Gainers

• AveXis, Inc. AVXS rose 85.1 percent to $214.60 in pre-market trading after the company agreed to be acquired by Novartis AG NVS for $8.7 billion.
• Therapix Biosciences Ltd. TRPX rose 32.5 percent to $6.60 in pre-market trading after the company disclosed topline results of Phase IIa study at Yale University for Tourette Syndrome program.
• REGENXBIO Inc. RGNX rose 23 percent to $33.45 in pre-market trading after dropping 3.89 percent on Friday.
• Verastem, Inc. VSTM shares rose 22.3 percent to $3.62 in pre-market trading after the company disclosed that the FDA has accepted New Drug Application for duvelisib.
• Cellect Biotechnology Ltd. APOP rose 16.8 percent to $7.58 in pre-market trading after the company reported that it has successfully completed a Proof of Concept study for ApoTainer.
• Audentes Therapeutics, Inc. BOLD rose 9.8 percent to $30.86 in pre-market trading after dropping 2.87 percent on Friday.
• Senseonics Holdings, Inc. SENS shares rose 7.5 percent to $4.00 in pre-market trading after gaining 5.68 percent on Friday.
• Marrone Bio Innovations, Inc. MBII shares rose 7.1 percent to $3.48 in pre-market trading after jumping 21.72 percent on Friday.
• Portola Pharmaceuticals, Inc. PTLA rose 6.8 percent to $33.00 in pre-market trading after falling 4.01 percent on Friday.
• JinkoSolar Holding Co., Ltd. JKS rose 6.3 percent to $20.31 in pre-market trading after falling 4.64 percent on Friday.
• bluebird bio, Inc. BLUE shares rose 5.7 percent to $172 in pre-market trading after falling 4.38 percent on Thursday.
• Leucadia National Corporation LUK rose 4.4 percent to $22.73 in pre-market trading after the company agreed to sell 48 percent of National Beef for $1.05 billion and its stake in Garcadia for $425 million. The company also announced a 25 million share buyback plan.
• Deutsche Bank AG (USA) DB shares rose 3.8 percent to $14.40 in pre-market trading after the bank named Christian Sewing as its new CEO. The bank’s new CEO announced plans to review investment banking business.
• Merck & Co., Inc. MRK rose 3.1 percent to $54.97 in pre-market trading after the company disclosed that its KEYTRUDA monotherapey met its primary endpoint in the Phase 3 KEYNOTE-042 study.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Menlo Therapeutics Inc. MNLO fell 51.7 percent to $17.00 in pre-market trading as the company disclosed that its Phase 2 trial of serlopitant for pruritus associated with atopic dermatitis did not meet primary and key secondary efficacy endpoints.
• New York Times Company NYT fell 6.8 percent to $22.00 in pre-market trading after rising 2.39 percent on Friday.
• Broadwind Energy, Inc. BWEN fell 6.3 percent to $2.84 afterclimbing 28.94 percent on Friday.
• Sibanye Gold Limited SBGL shares fell 6 percent to $3.75 in pre-market trading after rising 3.37 percent on Friday.
• SSLJ.com Limited SSLJ fell 5.2 percent to $4.93 in pre-market trading after dropping 2.80 percent on Friday.
• Yandex N.V. YNDX shares fell 4.9 percent to $37.47 in pre-market trading after declining 1.84 percent on Friday.